111 related articles for article (PubMed ID: 2333033)
1. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.
Waltman WD; McDaniel LS; Gray BM; Briles DE
Microb Pathog; 1990 Jan; 8(1):61-9. PubMed ID: 2333033
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
Crain MJ; Waltman WD; Turner JS; Yother J; Talkington DF; McDaniel LS; Gray BM; Briles DE
Infect Immun; 1990 Oct; 58(10):3293-9. PubMed ID: 1698178
[TBL] [Abstract][Full Text] [Related]
3. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
McDaniel LS; Yother J; Vijayakumar M; McGarry L; Guild WR; Briles DE
J Exp Med; 1987 Feb; 165(2):381-94. PubMed ID: 3546575
[TBL] [Abstract][Full Text] [Related]
4. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae.
Briles DE; Yother J; McDaniel LS
Rev Infect Dis; 1988; 10 Suppl 2():S372-4. PubMed ID: 3187321
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6B Streptococcus pneumoniae.
Crain MJ; Turner JS; Robinson DA; Coffey TJ; Brooks-Walter A; McDaniel LS; Briles DE
Microb Pathog; 1996 Oct; 21(4):265-75. PubMed ID: 8905615
[TBL] [Abstract][Full Text] [Related]
6. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.
Tart RC; McDaniel LS; Ralph BA; Briles DE
J Infect Dis; 1996 Feb; 173(2):380-6. PubMed ID: 8568299
[TBL] [Abstract][Full Text] [Related]
7. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.
Miyaji EN; Vadesilho CF; Oliveira ML; Zelanis A; Briles DE; Ho PL
Clin Vaccine Immunol; 2015 Feb; 22(2):213-20. PubMed ID: 25520146
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types.
McDaniel LS; McDaniel DO; Hollingshead SK; Briles DE
Infect Immun; 1998 Oct; 66(10):4748-54. PubMed ID: 9746574
[TBL] [Abstract][Full Text] [Related]
10. Characterization of selected strains of pneumococcal surface protein A.
Jedrzejas MJ; Lamani E; Becker RS
J Biol Chem; 2001 Aug; 276(35):33121-8. PubMed ID: 11413137
[TBL] [Abstract][Full Text] [Related]
11. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK
J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling.
Kolberg J; Aase A; Rødal G; Littlejohn JE; Jedrzejas MJ
FEMS Immunol Med Microbiol; 2003 Dec; 39(3):265-73. PubMed ID: 14642312
[TBL] [Abstract][Full Text] [Related]
13. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
14. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.
Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LCC
Microb Pathog; 2017 Aug; 109():233-238. PubMed ID: 28602840
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.
Ochs MM; Bartlett W; Briles DE; Hicks B; Jurkuvenas A; Lau P; Ren B; Millar A
Microb Pathog; 2008 Mar; 44(3):204-14. PubMed ID: 18006268
[TBL] [Abstract][Full Text] [Related]
16. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
Ren B; Szalai AJ; Thomas O; Hollingshead SK; Briles DE
Infect Immun; 2003 Jan; 71(1):75-85. PubMed ID: 12496151
[TBL] [Abstract][Full Text] [Related]
17. A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence.
Talkington DF; Crimmins DL; Voellinger DC; Yother J; Briles DE
Infect Immun; 1991 Apr; 59(4):1285-9. PubMed ID: 2004810
[TBL] [Abstract][Full Text] [Related]
18. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
[TBL] [Abstract][Full Text] [Related]
19. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
[TBL] [Abstract][Full Text] [Related]
20. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.
McDaniel LS; Ralph BA; McDaniel DO; Briles DE
Microb Pathog; 1994 Nov; 17(5):323-37. PubMed ID: 7723659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
